1
ALL1
Delic CorpYear
1
ALL1
2021DEALS // DEV.
1
ALL1
DealsCountry
1
ALL1
U.S.A1
ALL1
Ketamine Wellness CentersTherapeutic Area
1
ALL1
Psychiatry/PsychologyStudy Phase
1
ALL1
UndisclosedDeal Type
1
ALL1
PartnershipProduct Type
1
ALL1
Controlled SubstanceDosage Form
1
ALL1
Intravenous InfusionLead Product
1
ALL1
Ketamine HydrochlorideTarget
1
ALL1
NMDALead Product(s) : Ketamine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : Ketamine Wellness Centers
Deal Size : Undisclosed
Deal Type : Partnership
Details : Ketamine treatments have successfully repaired and improved these connections while also building new, healthy ones. PTSD damage can reappear over time if the treatment is stopped and no other support strategies are put in place.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
October 14, 2021
Lead Product(s) : Ketamine Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : Ketamine Wellness Centers
Deal Size : Undisclosed
Deal Type : Partnership